Literature DB >> 23456232

Impact of local surgical treatment on survival in young women with T1 breast cancer: long-term results of a population-based cohort.

Ye Won Jeon1, Jung Eun Choi, Heung Kyu Park, Ku Sang Kim, Jee Yeon Lee, Young Jin Suh.   

Abstract

The aim of this study was to analyze the effect of the type of local surgical treatment on survival in young women aged less than 40 years with T1 breast cancer. We analyzed data from 3,512 patients aged ≤40 years old who were diagnosed with T1 breast cancer from the Korean Breast Cancer Registry database between January 1988 and December 2006 and underwent either breast-conserving therapy (BCT) or mastectomy. The overall survival (OS) and breast-cancer-specific survival (BCSS) were compared between BCT and mastectomy. Of the 3,512 patients analyzed, 1,951 (55.6 %) underwent BCT, and 1,561 (44.4 %) underwent mastectomy. The median follow-up period was 111.0 (79.0-131.5) months. Overall, the 10-year OS rates for BCT and mastectomy were 95 and 92.1 %, respectively (p = 00004), and the 10-year BCSS rates for BCT and mastectomy patients were 96.9 and 94.9 %, respectively (p = 0.12). In node-negative patients, no significant difference was observed in either the OS (adjusted hazard ratio [HR] 1.072; 95 % CI, 0.750-1.5332, p = 0.704) or BCSS (adjusted HR 0.988; 95 % CI, 0.620-1.574, p = 0.960) rate between the BCT and mastectomy groups. In node-positive patients, no significant difference was observed in the OS (adjusted HR 1.634; 95 % CI, 0.982-2.272, p = 0.59) and BCSS (adjusted HR 1.410; 95 % CI, 0.755-2.633, p = 0.281) rates between the BCT and mastectomy groups. In this large, population-based analysis of young women with T1 breast cancer, the OS and BCSS were not different between BCT and mastectomy.

Entities:  

Mesh:

Year:  2013        PMID: 23456232     DOI: 10.1007/s10549-013-2456-7

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  3 in total

1.  Local Recurrence in Young Women with Breast Cancer: Breast Conserving Therapy vs. Mastectomy Alone.

Authors:  Dang Van Nguyen; Sang-Won Kim; Young-Taek Oh; O Kyu Noh; Yongsik Jung; Mison Chun; Dae Sung Yoon
Journal:  Cancers (Basel)       Date:  2021-04-29       Impact factor: 6.639

2.  The expression of CXCL13 and its relation to unfavorable clinical characteristics in young breast cancer.

Authors:  Lujia Chen; Zhongxi Huang; Guangyu Yao; Xiaoming Lyu; Jinbang Li; Xiaolei Hu; Yahong Cai; Wenji Li; Xin Li; Changsheng Ye
Journal:  J Transl Med       Date:  2015-05-20       Impact factor: 5.531

3.  Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival.

Authors:  Ye Won Jeon; Su Hwan Kang; Min Ho Park; Woosung Lim; Se Heun Cho; Young Jin Suh
Journal:  BMC Cancer       Date:  2015-11-06       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.